Doctors Question New Saliva Test for COVID-19

male patient giving saliva sample at doctor's office

Alex Dos Diaz / Verywell 

Key Takeaways

  • The FDA has granted emergency use authorization to a new rapid saliva test for COVID-19.
  • The test can help diagnose the virus in three hours.
  • SalivaDirect is less expensive and less invasive than other tests, but doctors are unsure how accurate it will be.

The Food and Drug Administration (FDA) recently granted emergency use authorization for a new rapid saliva test that could help diagnose COVID-19 in three hours. The test, created by researchers at Yale University, may help alleviate the strain on diagnostic resources in labs across the country. But doctors are concerned about its accuracy.

SalivaDirect, cleared by the FDA on August 15, is simpler, less expensive, and less invasive than using a nasopharyngeal swab to test for SARS-CoV-2, the virus that causes COVID-19. The test isn’t perfect, and there is some room for a false negative result. A pre-print publication in medRxiv found that the SalivaDirect test had comparable results to a nasopharyngeal swab 94% of the time.

"A few months ago, I would have said I would not be interested in this," Rajeev Fernando, MD, an infectious disease expert in Southampton, New York, tells Verywell. However, Fernando adds, “we’re still short on testing. We don’t have enough machines, and polymerase chain reaction (PCR) testing—the diagnostic test of choice—is very labor-intensive.”

A Faster Way to Test More People

Since some patients currently have to wait up to two weeks to get results of COVID-19, Fernando says this kind of rapid test may help reduce the backlog.

“I would use this more to test large populations or people who are not really sick,” he says. “It’s a good way to screen people who are low-risk. But if a patient has symptoms and gets a negative saliva test, I would follow that up with a PCR test.”

Richard Watkins, MD, an infectious disease physician in Akron, Ohio, is hopeful that this particular test may help free up testing capabilities for PCR tests and reduce supply issues with regard to testing swabs.

"On the one hand, I am happy that testing can be expanded, and this is a way to potentially get a lot more people tested," Watkins, who is also an associate professor of internal medicine at the Northeast Ohio Medical University, tells Verywell. “But on the other, I am concerned about the risk for false negative test results.”

How Does This Saliva Test Work?

With the SalivaDirect test, patients collect a sample of their own saliva under the guidance of a healthcare professional. Since the sample is collected by the patient, it could lower the risk of exposing healthcare workers to COVID-19, the FDA says.

SalivaDirect also doesn’t require any special type of swab or collection device. Instead, a saliva sample can be collected in any sterile container.

What This Means For You

This new saliva-based rapid test for COVID-19 could help determine if you’re positive for the virus, but it’s not perfect. If you test negative for COVID-19 with this method and are still having symptoms, ask for a more traditional test.

This isn’t the first saliva test to get FDA emergency use authorization; it’s actually the fifth, the agency said in a press release announcing SalivaDirect’s approval.

However, this test is unique in that medical personnel don’t need to separate a patient’s genetic material, called nucleic acid, from the sample.

“This is significant because the extraction kits used for this step in other tests have been prone to shortages in the past,” the FDA says. “Being able to perform a test without these kits enhances the capacity for increased testing, while reducing the strain on available resources.”

Currently, the NBA is using SalivaDirect to test asymptomatic players and staff, according to a press release from Yale. Now, with the FDA’s emergency use authorization, the testing is immediately available to other organizations and labs.

Ultimately, experts say this new test is a good supplemental diagnostic tool.

“I certainly think there is an indication for this test in this climate,” Fernando says. “But I wouldn’t only rely solely on it.”

The information in this article is current as of the date listed, which means newer information may be available when you read this. For the most recent updates on COVID-19, visit our coronavirus news page.

3 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. U.S. Food & Drug Administration. Coronavirus (COVID-19) update: FDA issues emergency use authorization to Yale School of Public Health for SalivaDirect, which uses a new method of saliva sample processing.

  2. Vogels CBF, Brackney D, Wang J, Kalinich CC. SalivaDirect: Simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance. Medrxiv. [epub ahed of print]. August 4, 2020. doi:10.1101/2020.08.03.20167791

  3. Greenwood M. Quick and affordable saliva-based COVID-19 test developed by Yale scientists receives FDA Emergency Use Authorization. Yale News.

By Korin Miller
Korin Miller is a health and lifestyle journalist who has been published in The Washington Post, Prevention, SELF, Women's Health, The Bump, and Yahoo, among other outlets.